Role of Pneumococcal Surface Protein C in Nasopharyngeal Carriage and Pneumonia and Its Ability To Elicit Protection against Carriage of Streptococcus pneumoniae

ABSTRACT Previous studies suggested that PspC is important in adherence and colonization within the nasopharynx. In this study, we conducted mutational studies to further identify the role PspC plays in the pathogenesis of pneumococci. pspC and/or pspA was insertionally inactivated in a serotype 2 Streptococcus pneumoniae strain and in a serotype 19 S. pneumoniae strain. In the mouse colonization model, pneumococcal strains with mutations in pspC were significantly attenuated in their abilities to colonize. In a mouse pneumonia model, strains with mutations in pspC were unable to infect or multiply within the lung. Using reverse transcriptase PCR we were able to demonstrate that pspC is actively transcribed in vivo, when the bacteria are growing in the nasal cavity and in the lungs. In the bacteremia model, a strain mutated for pspC alone behaved like the wild type, but the absence of both pspC and pspA caused accelerated clearance of the bacteria. Intranasal immunization with PspC with cholera toxin subunit B as an adjuvant protected against intranasal challenge. Evidence was also obtained that revertants that spontaneously acquired PspC expression could multiply and colonize the nasal tissue. This latter finding strongly indicates that pneumococci are actively metabolizing and growing while in the nasopharynx.

[1]  J. Yother,et al.  Requirement for Capsule in Colonization byStreptococcus pneumoniae , 2001, Infection and Immunity.

[2]  L. McDaniel,et al.  PspC, a Pneumococcal Surface Protein, Binds Human Factor H , 2001, Infection and Immunity.

[3]  L. McDaniel,et al.  Characterization of Binding of Human Lactoferrin to Pneumococcal Surface Protein A , 2001, Infection and Immunity.

[4]  L. Björck,et al.  Hic, a Novel Surface Protein of Streptococcus pneumoniae That Interferes with Complement Function* , 2000, The Journal of Biological Chemistry.

[5]  E. Tuomanen,et al.  Role of Novel Choline Binding Proteins in Virulence of Streptococcus pneumoniae , 2000, Infection and Immunity.

[6]  E. Tuomanen,et al.  The Polymeric Immunoglobulin Receptor Translocates Pneumococci across Human Nasopharyngeal Epithelial Cells , 2000, Cell.

[7]  J. Weiser,et al.  Differential Protein Expression in Phenotypic Variants of Streptococcus pneumoniae , 2000, Infection and Immunity.

[8]  M. Hostetter,et al.  Novel purification scheme and functions for a C3-binding protein from Streptococcus pneumoniae. , 2000, Biochemistry.

[9]  M. Hostetter,et al.  A pneumococcal protein that elicits interleukin-8 from pulmonary epithelial cells. , 2000, The Journal of infectious diseases.

[10]  J. Paton,et al.  Additive Attenuation of Virulence ofStreptococcus pneumoniae by Mutation of the Genes Encoding Pneumolysin and Other Putative Pneumococcal Virulence Proteins , 2000, Infection and Immunity.

[11]  D. Briles,et al.  The pspC Gene of Streptococcus pneumoniae Encodes a Polymorphic Protein, PspC, Which Elicits Cross-Reactive Antibodies to PspA and Provides Immunity to Pneumococcal Bacteremia , 1999, Infection and Immunity.

[12]  D. Briles,et al.  Pneumococcal Surface Protein A Inhibits Complement Activation by Streptococcus pneumoniae , 1999, Infection and Immunity.

[13]  M. Lipsitch.  Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. , 1999, Emerging infectious diseases.

[14]  S. Hammerschmidt,et al.  Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae. , 1999, Infection and immunity.

[15]  J. Weiser,et al.  Phase variation in colony opacity by Streptococcus pneumoniae. , 1998, Microbial drug resistance.

[16]  R. Dagan,et al.  Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. , 1997, The Pediatric infectious disease journal.

[17]  C. Rosenow,et al.  Contribution of novel choline‐binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae , 1997, Molecular microbiology.

[18]  E. Tuomanen,et al.  Oligosaccharides interfere with the establishment and progression of experimental pneumococcal pneumonia. , 1997, The Journal of infectious diseases.

[19]  S. Hammerschmidt,et al.  SpsA, a novel pneumococcal surface protein with specific binding to secretory Immunoglobulin A and secretory component , 1997, Molecular microbiology.

[20]  D. Briles,et al.  Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice. , 1997, Microbial pathogenesis.

[21]  D. Briles,et al.  Differences in virulence for mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production , 1997, Infection and immunity.

[22]  Y. Guo,et al.  Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. , 1997, The Journal of infectious diseases.

[23]  L. McDaniel,et al.  Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection , 1997, Infection and immunity.

[24]  Tetsuya Matsumoto,et al.  Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice , 1997, Infection and immunity.

[25]  E. Swiatlo,et al.  PspA and PspC: their potential for use as pneumococcal vaccines. , 1997, Microbial drug resistance.

[26]  J C Paton,et al.  The contribution of pneumolysin to the pathogenicity of Streptococcus pneumoniae. , 1996, Trends in microbiology.

[27]  C. Rosenow,et al.  Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae , 1996, Molecular microbiology.

[28]  D. Morrison,et al.  An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  E. Tuomanen,et al.  Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor , 1995, Nature.

[30]  E. Tuomanen,et al.  Relationship between colonial morphology and adherence of Streptococcus pneumoniae , 1995, Infection and immunity.

[31]  D. Briles,et al.  A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice , 1995, Infection and immunity.

[32]  H. Masure,et al.  Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization , 1994, Infection and immunity.

[33]  J. Joseph,et al.  Novel streptococcal-integration shuttle vectors for gene cloning and inactivation. , 1992 .

[34]  E. Swiatlo,et al.  Molecular localization of variable and conserved regions of pspA and identification of additional pspA homologous sequences in Streptococcus pneumoniae. , 1992, Microbial pathogenesis.

[35]  D. Briles,et al.  Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene , 1992, Journal of bacteriology.

[36]  D. Briles,et al.  Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis , 1992, Journal of bacteriology.

[37]  D. Briles,et al.  Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae , 1992, Infection and immunity.

[38]  J. Ferretti,et al.  Novel streptococcal-integration shuttle vectors for gene cloning and inactivation. , 1992, Gene.

[39]  L. McDaniel,et al.  Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae , 1990, Infection and immunity.

[40]  D. Briles,et al.  Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae , 1989, Infection and immunity.

[41]  L. McDaniel,et al.  Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae. , 1988, Reviews of infectious diseases.

[42]  L. McDaniel,et al.  Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA) , 1987, The Journal of experimental medicine.

[43]  L. McDaniel,et al.  Transformation of encapsulated Streptococcus pneumoniae , 1986, Journal of bacteriology.

[44]  B. E. Davidson,et al.  Construction of plasmid vectors for the detection of streptococcal promoters. , 1986, Gene.

[45]  G. Magnusson,et al.  Identification of an active disaccharide unit of a glycoconjugate receptor for pneumococci attaching to human pharyngeal epithelial cells , 1983, The Journal of experimental medicine.

[46]  L. Butler,et al.  Effect of transforming DNA on growth and frequency of mutation of Streptococcus pneumoniae , 1983, Journal of bacteriology.

[47]  O. Avery,et al.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES , 1944, The Journal of experimental medicine.

[48]  Maclyn McCarty,et al.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES , 1944, The Journal of experimental medicine.